Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tear film aqueous-mucin layer is a complex physiological compartment essential for maintaining the health and optical clarity of the ocular surface. Modern research describes it as a unified mucoaqueous gradient where mucins, produced by conjunctival goblet cells and corneal epithelium, are interspersed with the aqueous component secreted by the lacrimal glands [1][2]. This layer provides a smooth refractive surface for vision, lubricates the eyelids during blinking, and contains essential nutrients, electrolytes, and antimicrobial proteins like lysozyme and lactoferrin [3]. It also serves as a physical and chemical barrier against environmental pathogens and debris. Dysfunction of this layer, characterized by decreased volume or altered biochemical composition, is the primary driver of Dry Eye Disease (DED) [4]. Such deficiencies lead to tear hyperosmolarity, which triggers a cascade of ocular surface inflammation and epithelial damage [5]. Therapeutic interventions focus on supplementing the layer with artificial lubricants or stimulating the endogenous production of water and mucins through secretagogues [5]. Additionally, anti-inflammatory agents are used to break the "vicious circle" of dry eye and restore the natural homeostasis of the tear film [5].
Lubrication, osmotic stabilization, and stimulation of endogenous secretion to restore tear film homeostasis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear film aqueous-mucin layer.